These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Targeting NR4A1 (TR3) in cancer cells and tumors. Lee SO; Li X; Khan S; Safe S Expert Opin Ther Targets; 2011 Feb; 15(2):195-206. PubMed ID: 21204731 [TBL] [Abstract][Full Text] [Related]
7. Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling. Zhou F; Drabsch Y; Dekker TJ; de Vinuesa AG; Li Y; Hawinkels LJ; Sheppard KA; Goumans MJ; Luwor RB; de Vries CJ; Mesker WE; Tollenaar RA; Devilee P; Lu CX; Zhu H; Zhang L; Dijke PT Nat Commun; 2014 Mar; 5():3388. PubMed ID: 24584437 [TBL] [Abstract][Full Text] [Related]
8. The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists. Hedrick E; Lee SO; Safe S Mol Carcinog; 2017 Sep; 56(9):2066-2075. PubMed ID: 28418095 [TBL] [Abstract][Full Text] [Related]
9. Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy. Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S Endocr Relat Cancer; 2015 Oct; 22(5):831-40. PubMed ID: 26229035 [TBL] [Abstract][Full Text] [Related]
10. The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells. Shrestha R; Mohankumar K; Jin UH; Martin G; Safe S Mol Cancer Ther; 2021 Mar; 20(3):612-622. PubMed ID: 33277444 [TBL] [Abstract][Full Text] [Related]
11. Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists. Hedrick E; Li X; Cheng Y; Lacey A; Mohankumar K; Zarei M; Safe S Breast Cancer Res Treat; 2019 Aug; 177(1):29-40. PubMed ID: 31119568 [TBL] [Abstract][Full Text] [Related]
12. Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS). Lacey A; Hedrick E; Li X; Patel K; Doddapaneni R; Singh M; Safe S Oncotarget; 2016 May; 7(21):31257-69. PubMed ID: 27144436 [TBL] [Abstract][Full Text] [Related]
14. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells. Lee SO; Jin UH; Kang JH; Kim SB; Guthrie AS; Sreevalsan S; Lee JS; Safe S Mol Cancer Res; 2014 Apr; 12(4):527-538. PubMed ID: 24515801 [TBL] [Abstract][Full Text] [Related]
15. Zhang L; Martin G; Mohankumar K; Hampton JT; Liu WR; Safe S Mol Pharmacol; 2022 Jun; 102(2):80-91. PubMed ID: 35680166 [TBL] [Abstract][Full Text] [Related]
17. New Drug Candidate Targeting the 4A1 Orphan Nuclear Receptor for Medullary Thyroid Cancer Therapy. Zhang L; Liu W; Wang Q; Li Q; Wang H; Wang J; Teng T; Chen M; Ji A; Li Y Molecules; 2018 Mar; 23(3):. PubMed ID: 29498706 [TBL] [Abstract][Full Text] [Related]
18. Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer. Mohankumar K; Li X; Sridharan S; Karki K; Safe S Gynecol Oncol; 2019 Jul; 154(1):218-227. PubMed ID: 31053403 [TBL] [Abstract][Full Text] [Related]
19. Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis. Mohankumar K; Li X; Sung N; Cho YJ; Han SJ; Safe S Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32099996 [TBL] [Abstract][Full Text] [Related]
20. Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells. Lee SO; Li X; Hedrick E; Jin UH; Tjalkens RB; Backos DS; Li L; Zhang Y; Wu Q; Safe S Mol Endocrinol; 2014 Oct; 28(10):1729-39. PubMed ID: 25099012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]